Your browser is no longer supported. Please, upgrade your browser.
Settings
PRPH [NASD]
ProPhase Labs, Inc.
Index- P/E- EPS (ttm)-0.15 Insider Own23.20% Shs Outstand11.60M Perf Week-17.27%
Market Cap137.23M Forward P/E5.26 EPS next Y2.25 Insider Trans0.00% Shs Float8.79M Perf Month12.88%
Income-1.70M PEG- EPS next Q0.00 Inst Own4.20% Short Float1.24% Perf Quarter68.76%
Sales12.50M P/S10.98 EPS this Y-95.00% Inst Trans5.41% Short Ratio0.73 Perf Half Y630.25%
Book/sh0.93 P/B12.72 EPS next Y- ROA-10.80% Target Price15.55 Perf Year549.71%
Cash/sh1.06 P/C11.16 EPS next 5Y- ROE-14.80% 52W Range1.20 - 16.04 Perf YTD28.87%
Dividend- P/FCF274.46 EPS past 5Y10.50% ROI-28.90% 52W High-26.25% Beta0.10
Dividend %- Quick Ratio7.40 Sales past 5Y-14.90% Gross Margin29.90% 52W Low885.83% ATR1.34
Employees48 Current Ratio8.30 Sales Q/Q35.70% Oper. Margin-15.00% RSI (14)49.17 Volatility8.52% 10.25%
OptionableNo Debt/Eq0.93 EPS Q/Q-32.50% Profit Margin-12.90% Rel Volume5.22 Prev Close11.93
ShortableYes LT Debt/Eq0.93 Earnings- Payout- Avg Volume150.00K Price11.83
Recom- SMA20-2.34% SMA5014.64% SMA200151.95% Volume728,466 Change-0.84%
Jan-20-21Initiated Dawson James Buy $25
Jan-18-21 09:50PM  
Jan-15-21 05:21PM  
Jan-11-21 08:30AM  
Jan-05-21 12:10PM  
Dec-08-20 04:15PM  
Nov-16-20 08:30AM  
Nov-10-20 08:30AM  
Nov-02-20 08:30AM  
Oct-23-20 08:30AM  
Sep-30-20 05:04PM  
08:30AM  
Sep-23-20 04:10PM  
Sep-18-20 08:00AM  
Aug-11-20 08:47AM  
May-12-20 08:00AM  
Mar-29-20 08:34AM  
Mar-25-20 08:36AM  
Mar-11-20 10:54AM  
Mar-09-20 05:19PM  
Jan-09-20 11:31AM  
Nov-20-19 04:15PM  
Nov-12-19 09:35AM  
Oct-29-19 12:49PM  
Sep-11-19 02:23PM  
Aug-12-19 08:00AM  
Jul-11-19 03:01PM  
May-14-19 08:00AM  
Apr-28-19 09:08AM  
Apr-09-19 04:57PM  
Mar-26-19 08:00AM  
Jan-18-19 10:52AM  
Jan-17-19 05:10PM  
Dec-26-18 09:15AM  
Nov-19-18 07:30AM  
Nov-16-18 09:47AM  
Nov-14-18 07:30AM  
Aug-21-18 08:40AM  
Aug-20-18 10:48PM  
Aug-15-18 01:00PM  
Aug-14-18 07:55PM  
Jun-02-18 02:34PM  
May-14-18 09:53PM  
May-07-18 07:30PM  
Mar-21-18 09:06AM  
09:00AM  
Mar-16-18 10:23AM  
Feb-20-18 07:15PM  
Dec-22-17 08:00AM  
Dec-21-17 04:00PM  
Dec-19-17 04:30PM  
Nov-30-17 05:25PM  
Nov-24-17 08:48AM  
Nov-20-17 08:30PM  
Nov-13-17 08:30AM  
Nov-10-17 08:00AM  
Oct-03-17 12:46PM  
Sep-29-17 08:30AM  
Sep-26-17 04:05PM  
Aug-25-17 04:05PM  
Aug-17-17 11:11AM  
Aug-15-17 08:00PM  
Aug-11-17 08:00AM  
Jun-13-17 04:30PM  
May-17-17 09:04AM  
May-15-17 08:30AM  
Apr-05-17 04:10PM  
Mar-30-17 10:50AM  
Mar-29-17 05:05PM  
04:30PM  
Mar-13-17 12:11PM  
Mar-09-17 02:03PM  
Mar-02-17 01:04PM  
Feb-27-17 04:08PM  
08:00AM  
Feb-24-17 04:09PM  
Jan-13-17 09:06AM  
Jan-10-17 06:34AM  
06:34AM  
Jan-09-17 02:21PM  
09:12AM  
08:51AM  
07:35AM  
07:30AM  
Nov-23-16 10:50AM  
Nov-17-16 08:20AM  
Nov-16-16 04:30PM  
Nov-15-16 03:14PM  
03:08PM  
Nov-14-16 08:00AM  
Aug-11-16 12:30PM  
11:29AM  
Aug-10-16 06:10AM  
Aug-09-16 06:15PM  
07:07AM  
Aug-05-16 12:11PM  
Jun-01-16 02:36PM  
May-26-16 06:08AM  
May-13-16 01:08PM  
May-11-16 05:27PM  
May-10-16 04:10PM  
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter (OTC) consumer healthcare products and dietary supplements in the United States. It offers a range of OTC dietary supplements, including Legendz XL for sexual health; Triple Edge XL, an energy booster and testosterone support product; and Super ProstaFlow+ a supplement to support prostate and urinary health under the TK Supplements brand. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; and offers COVID-19 and other respiratory pathogen panel testing services. It serves consumer products companies, as well as large national chain, regional, specialty, and local retail stores. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Doylestown, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLECKEL LOUIS MDDirectorAug 13Buy2.7550,000137,500273,840Aug 17 04:30 PM
Karkus Ted WilliamCEO & CHAIRMANAug 13Sale2.7550,000137,5002,419,528Aug 17 04:30 PM
GLECKEL LOUIS MDDirectorMar 26Buy1.75100,000175,000209,894Mar 27 07:17 PM
Karkus Ted WilliamCEO & CHAIRMANMar 26Sale1.75100,000175,0002,549,528Mar 27 07:15 PM